Table 3 The efficiency of NIPT in screening other chromosomal aneuploidies
From: Clinical application of noninvasive prenatal testing in the detection of fetal chromosomal diseases
NIPT results | Positive (N) | TP (N) | FP (N) | Unverified (N) | PPV (%) |
|---|---|---|---|---|---|
T1 | 1 | 0 | 1 | 0 | 0 |
T2 | 2 | 1 | 1 | 0 | 50.00 |
T3 | 1 | 0 | 1 | 0 | 0 |
T7 | 9 | 0 | 3 | 6 | 0 |
T8 | 5 | 0 | 3 | 2 | 0 |
T9 | 2 | 1 | 1 | 0 | 50.00 |
T10 | 3 | 0 | 3 | 0 | 0 |
T12 | 1 | 0 | 1 | 0 | 0 |
T14 | 1 | 0 | 1 | 0 | 0 |
T15 | 2 | 0 | 2 | 0 | 0 |
T16 | 4 | 1 | 3 | 0 | 25.00 |
T17 | 1 | 0 | 0 | 1 | 0 |
T20 | 2 | 0 | 1 | 1 | 0 |
T21mos | 5 | 1 | 3 | 1 | 25.00 |
T18mos | 5 | 0 | 5 | 0 | 0 |
T13mos | 3 | 0 | 3 | 0 | 0 |